The role of interleukin-12 in the pathogenesis of psoriasis

被引:53
作者
Shaker, OG [1 ]
Moustafa, W
Essmat, S
Abdel-Halim, M
El-Komy, M
机构
[1] Cairo Univ, Fac Med, Dept Biochem, Cairo, Egypt
[2] Cairo Univ, Dept Dermatol, Fac Med, Cairo, Egypt
关键词
psoriasis; interleukin-12; interferon gamma; in situ PCR;
D O I
10.1016/j.clinbiochem.2005.11.008
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To verify the role of IL-12 in the pathogenesis of psoriasis and determine its relation to IFN gamma. Design and methods: Skin biopsies from lesional and non-lesional skin of 30 patients and 10 healthy controls were obtained for quantitative PCR examination of IL-12 (P40) and IFN-gamma rnRNA as well as in situ PCR of IL-12 (P40) and IFN-gamma mRNA. Results: IL-12 and IFN-gamma levels were higher in lesional skin than in non-lesional and control skin. A significant correlation between IL-12 and IFN gamma was found. By in situ PCR hybridization, IL-12 expression was only found in the dermis, while IFN-gamma was invariably expressed in the dermis and/or epidermis. Conclusion: We suggest that IL-12 independently and through IFN gamma induction may have a crucial role in the development of the active psoriatic lesion itself. where it is probably produced locally in the dermis as a step in the evolution of the psoriatic lesion. (c) 2005 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 38 条
[1]   The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients [J].
Austin, LM ;
Ozawa, M ;
Kikuchi, T ;
Walters, IB ;
Krueger, JG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) :752-759
[2]   The pathogenesis of psoriasis: Immunological facts and speculations [J].
Bos, JD ;
De Rie, MA .
IMMUNOLOGY TODAY, 1999, 20 (01) :40-46
[3]   Genetics of psoriasis: The potential impact on new therapies [J].
Bowcock, AM ;
Barker, JN .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) :S51-S56
[4]   CD8+ T-CELLS IN PSORIATIC LESIONS PREFERENTIALLY USE T-CELL RECEPTOR V(BETA)3 AND/OR V(BETA)13.1 GENES [J].
CHANG, JCC ;
SMITH, LR ;
FRONING, KJ ;
SCHWABE, BJ ;
LAXER, JA ;
CARALLI, LL ;
KURLAND, HH ;
KARASEK, MA ;
WILKINSON, DI ;
CARLO, DJ ;
BROSTOFF, SW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9282-9286
[5]   Role of costimulation in the induction of the IL-12/PL-12 receptor pathway and the development of autoimmunity [J].
Chang, JT ;
Segal, BM ;
Shevach, EM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :100-106
[6]   Multiple-cell modeling of fiber-reinforced composites with the presence of interphases using the boundary element method [J].
Chen, XL ;
Liu, YJ .
COMPUTATIONAL MATERIALS SCIENCE, 2001, 21 (01) :86-94
[7]   Plasma concentrations of IFN-γ and TNF-α in psoriatic patients before and after local treatment with dithranol ointment [J].
Chodorowska, G .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 1998, 10 (02) :147-151
[8]   PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
DANDREA, A ;
RENGARAJU, M ;
VALIANTE, NM ;
CHEHIMI, J ;
KUBIN, M ;
ASTE, M ;
CHAN, SH ;
KOBAYASHI, M ;
YOUNG, D ;
NICKBARG, E ;
CHIZZONITE, R ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1387-1398
[9]   Effects of cyclosporin A on immune activation markers in patients with active psoriasis [J].
Economidou, J ;
Barkis, J ;
Demetriou, Z ;
Avgerinou, G ;
Psarra, K ;
Degiannis, D ;
Vareltzidis, A ;
Katsambas, A .
DERMATOLOGY, 1999, 199 (02) :144-148
[10]   UVB induces IL-12 transcription in human keratinocytes in vivo and in vitro [J].
Enk, CD ;
Mahanty, S ;
Blauvelt, A ;
Katz, SI .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1996, 63 (06) :854-859